Six of 10 (60%) families carrying POLE/POLD1 variants had at least two family members with brain tumors (Fig. 1a-c, e, h, j; Table 2), with gliomas occurring together with meningiomas in two families (Fig. 1e, h). This evidence concerns the gene POLD1 and central nervous system cancer.